1. Home
  2. ROIV vs FSV Comparison

ROIV vs FSV Comparison

Compare ROIV & FSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • FSV
  • Stock Information
  • Founded
  • ROIV 2014
  • FSV 1988
  • Country
  • ROIV United Kingdom
  • FSV Canada
  • Employees
  • ROIV N/A
  • FSV N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • FSV Real Estate
  • Sector
  • ROIV Health Care
  • FSV Finance
  • Exchange
  • ROIV Nasdaq
  • FSV Nasdaq
  • Market Cap
  • ROIV 8.4B
  • FSV 7.8B
  • IPO Year
  • ROIV N/A
  • FSV N/A
  • Fundamental
  • Price
  • ROIV $10.79
  • FSV $175.63
  • Analyst Decision
  • ROIV Buy
  • FSV Buy
  • Analyst Count
  • ROIV 4
  • FSV 5
  • Target Price
  • ROIV $17.50
  • FSV $203.00
  • AVG Volume (30 Days)
  • ROIV 5.9M
  • FSV 100.5K
  • Earning Date
  • ROIV 05-29-2025
  • FSV 04-24-2025
  • Dividend Yield
  • ROIV N/A
  • FSV 0.62%
  • EPS Growth
  • ROIV N/A
  • FSV 42.94
  • EPS
  • ROIV N/A
  • FSV 2.88
  • Revenue
  • ROIV $122,585,000.00
  • FSV $5,309,675,000.00
  • Revenue This Year
  • ROIV N/A
  • FSV $7.67
  • Revenue Next Year
  • ROIV N/A
  • FSV $6.82
  • P/E Ratio
  • ROIV N/A
  • FSV $60.93
  • Revenue Growth
  • ROIV 140.04
  • FSV 18.68
  • 52 Week Low
  • ROIV $8.73
  • FSV $141.26
  • 52 Week High
  • ROIV $13.06
  • FSV $197.84
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 50.06
  • FSV 55.86
  • Support Level
  • ROIV $10.58
  • FSV $171.01
  • Resistance Level
  • ROIV $11.77
  • FSV $177.89
  • Average True Range (ATR)
  • ROIV 0.34
  • FSV 2.97
  • MACD
  • ROIV -0.07
  • FSV 0.00
  • Stochastic Oscillator
  • ROIV 17.65
  • FSV 72.10

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About FSV FirstService Corporation

FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.

Share on Social Networks: